Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Michael Snyder
AddedApr 2, 2024
UpdatedJun 25, 2026
Michael Snyder

Michael Snyder

Scientific Co-founder, Quinn· 2022 – present · 4 yrs

Crunchbase

Michael Snyder's Career

Quinn
Quinn

San Francisco, CA, US

Scientific Co-founder· Science
2022 – present · 4 yrs
Q Bio
Q Bio

San Carlos, CA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Michael Snyder's Career

Quinn
Quinn
Pre-Seed$1M32022San Francisco, CA, US
Scientific Co-founder· Science
2022 – present · 4 yrs

Recent news

‘It’s like Theranos, but it works’: Stanford team plans at-home blood testsSTAT News · 2023
‘Theranos that works’: Stanford researchers say they’ve measured thousands of molecules from a single drop of bloodThe Stanford Daily · 2023
A geneticist studied one drop of his blood – and saw things he couldn't from a vial of bloodUSA TODAY · 2023

Leadership at Quinn

Daniel GomariDaniel GomariFounder and CEO
Brent LaRueBrent LaRueCo-founder
Jan KrumsiekJan KrumsiekCo-founder
David WishartDavid WishartScientific Advisor
Jordan LiptonJordan LiptonMedical Advisory Member

Similar to Quinn

ViomeViomeBellevue, WA, USHealth Testing, Supplementsest. 2016ViomeBellevue, WA, US · est. 2016

Bellevue-based Viome offers nutritional genomics testing, gut flora analysis, and personalized dietary advice.

Series C · $276M200
InsideTrackerInsideTrackerCambridge, MA, USHealth Analysisest. 2009InsideTrackerCambridge, MA, US · est. 2009

InsideTracker: Optimizing personal health for longevity and vitality from the inside out.

Series B · $18.2M101
SuperpowerSuperpowerSan Francisco, CA, USBiomarker Testingest. 2023SuperpowerSan Francisco, CA, US · est. 2023

Superpower provides comprehensive biomarker testing and AI-powered longevity protocols for proactive health management.

Series A · $34M166
Function HealthFunction HealthLos Angeles, CA, USHealth Data, Lab Testsest. 2021Function HealthLos Angeles, CA, US · est. 2021

A health data platform that includes 100+ lab tests with insights for all major biological functions.

Seed · $3M25
Q Bio
Q Bio
Series B$64M502015San Carlos, CA, US
Co-Founder

Leadership at Q Bio

Vijay PandeVijay PandeBoard Member
Jeffrey KaditzJeffrey KaditzCo-Founder
Garry ChoyGarry ChoyCo-Founder
Clarissa ShenClarissa ShenBoard Member

Similar to Q Bio

QuantivlyQuantivlyBoston, MA, USData Analyticsest. 2019QuantivlyBoston, MA, US · est. 2019

Data-driven decision tool empowering radiology through precise data analysis.

Pre-Seed · $2.1M12
Q BioMedQ BioMedNew York City, NY, USBiomedical Assetsest. 2013Q BioMedNew York City, NY, US · est. 2013

QBioMed Inc.: A dedicated biomedical development firm, accelerating and providing strategic resources.

Public · $48M9
ProbiusProbiusFremont, CA, USBiotech, Diagnosticsest. 2016ProbiusFremont, CA, US · est. 2016

ProbiusDx: A deep-tech firm providing diagnostic tech for blood monitoring.

Series B · $12.9M13
QbDVisionQbDVisionAustin, TX, USPlatform, Softwareest. 2016QbDVisionAustin, TX, US · est. 2016

QbDVision: A pioneering biopharma platform transforming fragmented data into process intelligence.

Series A · $17M45

Michael Snyder's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoJB LEEJB LEECo-Founder · Kakao

People Similar to Michael Snyder

Christopher MasonChristopher MasonCo-Founder · BiotiaSpencer WellsSpencer WellsCo-Founder · InsitomeJay ShendureJay ShendureBoard Member · Adaptive BiotechnologiesCarlos BustamanteCarlos BustamanteCo-Founder · Arc BioDietrich StephanDietrich StephanFounder & CEO · LifeXChengcang Charles WuChengcang Charles WuFounder · Intact Genomics